Abstract:BACKGROUNDThe objective of this study was to investigate the antitumor activity of selectively expanded gammadelta T cells in tumor-infiltrating lymphocytes (gammadeltaTILs) or tumor ascites lymphocytes (gammadeltaTALs) from patients with colorectal and ovarian epithelial carcinoma (OEC) in vitro and in vivo.METHODSgammadeltaTILs/TALs were expanded by the solid-phase antibody method; their cytolytic and proliferative activities in vitro were detected by the MTT method and 3H-TdR incorporation and their effect in vivo was evaluated by the nude mice model.RESULTSExpanded gammadeltaTILs from colorectal tumors demonstrated marked cytotoxicities to allogeneic human colon adenocarcinoma HR8348 and lymphoma Daudi cells, as well as xenogeneic murine thymoma EL-4 cell lines. Cytokines, including IL-2, IL-4, IL-12, IL-15, TNF-alpha and INF-gamma, could promote the cytotoxicities of gammadeltaTILs to tumor cells, whereas IL-10, GM-CSF and TFG-beta had no effect on such killing activities. Rested gammadeltaTILs could proliferate strongly in response to mitomycin C-treated Daudi and EL-4 tumor cells, but not to HR8348 tumor cells, suggesting that the latter might possess only cytotoxicity-related antigen recognized by gammadeltaTILs. Either alphabetaTILs or gammadeltaTILs from patients with OEC displayed cytotoxicities to allogeneic or autologous OEC cell lines at a similar strength in vitro. Transferring gammadeltaTILs into Daudi cell-bearing BALB/c nude mice with an injection of IL-2 was able to maintain a high survival rate of the mice for 30 days, when compared with mice treated with alphabetaTILs or without any treatment (p < 0.05). Without coinjection of IL-2, after 3 months of Daudi tumor inoculation, a high survival rate was observed in gammadeltaTIL-treated mice. Similarly, adoptive gammadeltaTALs from the ascites of patients with OEC transferred into nude mice displayed a stronger antitumor response to OEC SKOV3 cells than alphabetaTALs in vivo. Tumor volumes in gammadeltaTAL-treated mice were smaller than in alphabetaTAL-treated or non-TAL-treated mice within the period from day 23 to day 50 after tumor inoculation (p < 0.05). Fifty days after SKOV3 tumor inoculation, a decreasing trend of carcinogenic rate was observed in gammadeltaTAL-treated nude mice.CONCLUSIONTaken together, our results suggest that gammadeltaT cells could be a new candidate for adoptive immunotherapy in the future treatment of patients with cancer.

Gadd45b and Gadd45g are important for anti-tumor immune responses.

Gadd45 Beta Is Important For Cd8+T Cell Mediated Tumor Surveillance

Absence Of Gamma-Interferon-Inducible Lysosomal Thiol Reductase (Gilt) Is Associated With Poor Disease-Free Survival In Breast Cancer Patients (Vol 9, E109449, 2014)

Antitumor Activity of Expanded Human Tumor-Infiltrating Gammadelta T Lymphocytes.

Gadd45a Function in Suppressing Cell Transformation and Tumor Malignancy

Gadd45a Regulates Hematopoietic Stem Cell Stress Responses in Mice.

Gadd45a inhibits cell migration and invasion by altering the global RNA expression.

Abnormal expression of GADD45B in human colorectal carcinoma

Gadd45a Suppresses Tumor Angiogenesis via Inhibition of the mTOR/STAT3 Protein Pathway*

Hmgb1-IL-23-IL-17-IL-6-Stat3 Axis Promotes Tumor Growth in Murine Models of Melanoma

MicroRNA-383 Regulates the Apoptosis of Tumor Cells Through Targeting Gadd45g

Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT

Role of Gadd45 Protein Family in Tumorigenesis and Development

Vgamma4 Gamma-Delta T Cells Are Essential for Gamma-Delta T Cell-Mediated Tumor Immune Surveillance

HEMATOPOIESIS AND STEM CELLS Gadd 45 a regulates hematopoietic stem cell stress responses in mice

Expression of Gadd45a and P53 Proteins in Human Pancreatic Cancer: Potential Effects on Clinical Outcomes

Gadd45a Gene Silencing by RNAi Promotes Cell Proliferation and Inhibits Apoptosis and Senescence in Skin Squamous Cell Carcinoma Through the P53 Signaling Pathway.

Gadd45a contributes to p53 stabilization in response to DNA damage

The Gadd45 Inhibition Of Cdc2 Kinase Correlates With Gadd45-Mediated Growth Suppression

Gadd45g initiates embryonic stem cell differentiation and inhibits breast cell carcinogenesis

The Central Region of Gadd45 is Required for Its Interaction with P21/waf1.